Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences [Yahoo! Finance]
Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ:AMEX Investor Relations:
ir.citiuspharma.com
Company Research
Source: Yahoo! Finance
The Think Equity Conference, October 30, 2025 CRANFORD, N.J. Oct. 17, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) and Citius Oncology, Inc. (Nasdaq: CTOR) today announced that management will be participating in three investor conferences in October 2025. Citius Pharmaceuticals (Nasdaq: CTXR) Event: LD Micro Main Event XIX Date: October 19-21, 2025 Location: Hotel Del Coronado, San Diego, California Event website: Conference registration Event: Think Equity Conference Date: October 30, 2025 Location: Mandarin Oriental, New York Event website: Conference registration Interested parties may schedule 1-on-1 meetings with Citius management by registering through the event platform or contacting the Company's investor relations team. Citius Oncology (Nasdaq: CTOR) Event: 2025 Maxim Growth Summit Date: October 22-23, 2025 Location: The Hard Rock Hotel, New York Event website: Conference Registration Citius Oncol
Show less
Read more
Impact Snapshot
Event Time:
CTXR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTXR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTXR alerts
High impacting Citius Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CTXR
News
- Citius Pharmaceuticals (NASDAQ:CTXR) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $6.00 price target on the stock.MarketBeat
- Citius Pharmaceuticals (NASDAQ:CTXR) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq RulesPR Newswire
- Citius Pharmaceuticals Announces a Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq RulesPR Newswire
- Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 ConferencesPR Newswire
CTXR
Earnings
- 5/14/25 - Beat
CTXR
Sec Filings
- 12/1/25 - Form 8-K
- 10/27/25 - Form SCHEDULE
- 10/23/25 - Form 8-K
- CTXR's page on the SEC website